Verastem, Inc. (VSTM)
7.335
0.00 (0.00%)
USD |
NASDAQ |
Sep 16, 16:00
7.44
+0.10
(+1.43%)
After-Hours: 17:24
Verastem Market Cap : 663.68M for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 664.13M |
| September 14, 2026 | 679.52M |
| September 11, 2026 | 662.33M |
| September 10, 2026 | 689.47M |
| September 09, 2026 | 718.42M |
| September 08, 2026 | 731.09M |
| September 04, 2026 | 741.95M |
| September 03, 2026 | 722.04M |
| September 02, 2026 | 725.66M |
| September 01, 2026 | 688.56M |
| August 31, 2026 | 653.28M |
| August 28, 2026 | 653.28M |
| August 27, 2026 | 667.75M |
| August 26, 2026 | 668.66M |
| August 25, 2026 | 640.61M |
| August 24, 2026 | 620.70M |
| August 21, 2026 | 623.42M |
| August 20, 2026 | 617.08M |
| August 19, 2026 | 660.06M |
| August 18, 2026 | 672.28M |
| August 17, 2026 | 649.66M |
| August 14, 2026 | 595.37M |
| August 13, 2026 | 603.51M |
| August 12, 2026 | 628.85M |
| August 11, 2026 | 637.90M |
| Date | Value |
|---|---|
| August 10, 2026 | 614.37M |
| August 07, 2026 | 609.85M |
| August 06, 2026 | 534.75M |
| August 05, 2026 | 531.13M |
| August 04, 2026 | 525.70M |
| August 03, 2026 | 499.83M |
| July 31, 2026 | 509.49M |
| July 30, 2026 | 535.84M |
| July 29, 2026 | 527.94M |
| July 28, 2026 | 547.26M |
| July 27, 2026 | 534.09M |
| July 24, 2026 | 531.45M |
| July 23, 2026 | 542.87M |
| July 22, 2026 | 517.40M |
| July 21, 2026 | 527.06M |
| July 20, 2026 | 505.10M |
| July 17, 2026 | 529.69M |
| July 16, 2026 | 506.85M |
| July 15, 2026 | 503.34M |
| July 14, 2026 | 489.29M |
| July 13, 2026 | 471.72M |
| July 10, 2026 | 485.77M |
| July 09, 2026 | 474.35M |
| July 08, 2026 | 446.24M |
| July 07, 2026 | 426.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.737B |
| Dianthus Therapeutics, Inc. | 5.616B |
| Alnylam Pharmaceuticals, Inc. | 32.03B |
| Anika Therapeutics, Inc. | 279.17M |
| Savara, Inc. | 1.056B |
Market Cap Related Metrics
| PS Ratio | 7.437 |
| Price to Book Value | 13.28 |
| Price | 7.335 |
| Earnings Yield | -33.54% |